1,021 results on '"Burger, Irene"'
Search Results
2. Cardiotoxicity as important differential diagnosis for reduced myocardial blood flow during Rubidium cardiac PET/CT: Cardiotoxicity in Rubidium PET/CT
3. Equivocal bone lesions on PSMA PET/CT: systematic review and meta-analysis on their prevalence and malignancy rate
4. Quantification of [99mTc]Tc-HDP bone SPECT/CT: can we improve the body weight based standardized uptake value with a more robust normalization?
5. Evaluating the biodistribution for [68Ga]Ga-PSMA-11 and [18F]F-PSMA-1007 PET/CT with an inter- and intrapatient based analysis
6. Relaxed fibronectin: a potential novel target for imaging endometriotic lesions
7. Unspecific bone uptakes in PSMA PET for prostate cancer: why do they matter?
8. PSMA-positive prostatic volume prediction with deep learning based on T2-weighted MRI
9. A third of the radiotracer dose: two decades of progress in pediatric [18F]fluorodeoxyglucose PET/CT and PET/MR imaging
10. Fully automated computational measurement of noise in positron emission tomography
11. Correction: PSMA‑positive prostatic volume prediction with deep learning based on T2‑weighted MRI
12. Single-nucleus transcriptomics identifies separate classes of UCP1 and futile cycle adipocytes
13. 68Ga-FAPi: Pathways and Diagnosis in Cardiac Imaging
14. Highlights of the 35th EANM Annual Congress 2022, onsite edition in Barcelona, Spain: “FROM BARCELONA WITH LOVE”
15. Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer
16. Prostate Cancer
17. Advances in Molecular Imaging and Therapy and Its Impact in Oncologic Imaging
18. European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer
19. Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer?
20. Combined forced diuresis and late acquisition on [68Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study
21. Immunohistochemical Expression Pattern of Theragnostic Targets SSTR2 and PSMA in Endolymphatic Sac Tumors: A Single Institution Case Series
22. Whole-Body 18F-FDG PET/CT Patlak Parametric Imaging of Hepatic Alveolar Echinococcosis
23. Prediction of pelvic lymph node metastases and PSMA PET positive pelvic lymph nodes with multiparametric MRI and clinical information in primary staging of prostate cancer
24. Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI
25. Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [68Ga]Ga-PSMA-11 PET scans of primary prostate cancer.
26. Correction to: Highlights of the 35th EANM Annual Congress 2022, onsite edition in Barcelona, Spain: “FROM BARCELONA WITH LOVE”
27. Highlights of the 34th EANM Annual Congress 2021, 2nd virtual edition: “FROM HAMBURG WITH LOVE”
28. Hot needles can confirm accurate lesion sampling intraoperatively using [18F]PSMA-1007 PET/CT-guided biopsy in patients with suspected prostate cancer
29. Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients
30. Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics
31. 68Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement
32. Molecular Imaging of Vulnerable Plaque
33. Cardiac Amyloidosis
34. [18F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impact
35. Focal unspecific bone uptake on [18F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging
36. What’s behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns
37. 68Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer
38. Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study
39. Value of bowel preparation techniques for prostate MRI: a preliminary study
40. Quantification of [99mTc]Tc-HDP bone SPECT/CT: can we improve the body weight based standardized uptake value with a more robust normalization?
41. Subcutaneous Uptake on [18F]Florbetaben PET/CT: a Case Report of Possible Amyloid-Beta Immune-Reactivity After COVID-19 Vaccination
42. Enhanced prognostic stratification of neoadjuvant treated lung squamous cell carcinoma by computationally-guided tumor regression scoring
43. Diagnostic Accuracy of PET/CT and Contrast Enhanced CT in Patients With Suspected Infected Aortic Aneurysms
44. Association between vertebral bone mineral density, myocardial perfusion, and long-term cardiovascular outcomes: A sex-specific analysis
45. Improved oncological outcome after radical prostatectomy in patients staged with 68Ga-PSMA-11 PET: a single-center retrospective cohort comparison
46. Radiopharmaceuticals in Genitourinary Cancers: A Fast-evolving Field with a Bright Perspective.
47. European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer
48. Evaluating the biodistribution for [$^{68}$Ga]Ga-PSMA-11 and [$^{18}$F]F-PSMA-1007 PET/CT with an inter- and intrapatient based analysis
49. Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy
50. Sex-dependent association between inflammation, neural stress responses, and impaired myocardial function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.